Cholangitis Clinical Trial
Official title:
Best Biliary Drainage Option in Type II、III、IV Klatskin Tumor:ERCP or PTBD
Verified date | July 2019 |
Source | Hepatopancreatobiliary Surgery Institute of Gansu Province |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To investigate the biliary drainage-related cholangitis and other complications of percutaneous transhepatic biliary drainage (PTBD) in the management of Klatskin tumor (KT) compared with endoscopic biliary drainage (EBD).
Status | Completed |
Enrollment | 180 |
Est. completion date | July 14, 2017 |
Est. primary completion date | July 14, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Type II?III?IV Klatskin tumor patients; - 18-90 years old Exclusion Criteria: - Unwillingness or inability to consent for the study; - Coagulation dysfunction (INR> 1.3) and low peripheral blood platelet count(<50×109 / L) or using anti-coagulation drugs; - Previous endoscopic sphincterectomy (EST) or endoscopic papillary balloon dilatation (EPBD); - Any type of GI reconstruction; - Combined with Mirizzi syndrome and intrahepatic bile duct stones; - Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease, primary sclerosing cholangitis (PSC), septic shock; - Biliary-duodenal fistula; - Pregnant women |
Country | Name | City | State |
---|---|---|---|
China | Hepatopancreatobiliary Surgery Institute of Gansu Province | Lanzhou | Gansu |
Lead Sponsor | Collaborator |
---|---|
Hepatopancreatobiliary Surgery Institute of Gansu Province |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Acute cholangitis | Acute cholangitis is defined if patients experienced abdominal pain, high fever, or chill after procedure in 2 weeks | 2 weeks | |
Secondary | Abdominal pain | Pain score (scores:1-10) | 2 weeks | |
Secondary | Length of hospital stay | The total time of hospital stay | 6 months | |
Secondary | Overall procedure related complication rate | Pancreatitis, bleeding, perforation, seeding | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
Withdrawn |
NCT02543957 -
Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
|
||
Completed |
NCT02461147 -
Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
|
||
Completed |
NCT01824186 -
Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy
|
N/A | |
Terminated |
NCT00990366 -
Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve
|
N/A | |
Completed |
NCT02594891 -
Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis
|
N/A | |
Terminated |
NCT01142921 -
The Patency Period of the New Plastic Anti-reflux Biliary Stent
|
N/A | |
Completed |
NCT04604652 -
Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
|
Phase 2 | |
Terminated |
NCT02034279 -
The INFECIR-2 Albumin Prevention Study
|
Phase 4 | |
Completed |
NCT04671095 -
Single Use ERCP Performance -SURE Study
|
||
Recruiting |
NCT03087656 -
Antibiotics to Decrease Post ERCP Cholangitis
|
Phase 4 | |
Completed |
NCT02098486 -
Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP
|
Phase 2 | |
Withdrawn |
NCT03678480 -
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
Recruiting |
NCT04216745 -
Microbial Analysis in Patients With Cholangitis
|
||
Recruiting |
NCT03133026 -
Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation
|
N/A | |
Terminated |
NCT02618668 -
Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography
|
Phase 2 | |
Recruiting |
NCT01438385 -
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
|
N/A | |
Recruiting |
NCT05750966 -
Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
|
N/A | |
Recruiting |
NCT06111872 -
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
|
Phase 2 | |
Recruiting |
NCT05464303 -
Definition for Biliary Atresia Associated Cholangitis After Surgery
|